Long-term results in mizoribine-treated renal transplant recipients: A prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression

Transplantation Proceedings

Volumn 31, Issue 7, 1999, Pages 2877-2879

  Tanabe, K ^a   Tokumoto, T ^a   Ishikawa, N ^a   Kanematsu, A ^a   Oshima, T ^a   Harano, M ^a   Inui, M ^a   Yagisawa, T ^a   Nakajima, I ^a   Fuchinoue, S ^a   Takahashi, K ^b   Toma, H ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MIZORIBINE;

ADOLESCENT; ADULT; BLOOD GROUP ABO SYSTEM; BONE MARROW SUPPRESSION; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT;

ADOLESCENT; ADULT; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RIBONUCLEOSIDES; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0032719498     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00599-0     Document Type: Conference Paper

References (6)

1. Mizuno K., Tsujino M., Takeda M., et al. J Antibiotics. 27:1997;775.
2. Mita K., Akiyama N., Nagao H., et al. Transplant Proc. 22:1990;1679.
3. Lee H.A., Slapak M., Raman G.V., et al. Transplant Proc. 27:1995;1050.
4. Tajima A., Hata M., Ohta N., et al. Transplantation. 38:1984;116.
5. Sakaguchi K., Tsujino M., Yoshizawa M., et al. Cancer Res. 35:1975;1643.
6. Lancet. 345:1995;1321.